Bicocca Open Archive

Logo unimib boa
VILLA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.152
AS - Asia 2.143
EU - Europa 1.768
SA - Sud America 340
Continente sconosciuto - Info sul continente non disponibili 102
AF - Africa 56
OC - Oceania 12
Totale 6.573
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.047
IT - Italia 853
SG - Singapore 624
VN - Vietnam 484
CN - Cina 419
BR - Brasile 266
HK - Hong Kong 223
RU - Federazione Russa 194
DE - Germania 156
FR - Francia 94
IE - Irlanda 78
GB - Regno Unito 72
BD - Bangladesh 68
IN - India 67
CA - Canada 65
SE - Svezia 62
KR - Corea 55
ID - Indonesia 47
FI - Finlandia 41
NL - Olanda 39
ES - Italia 35
CH - Svizzera 31
PL - Polonia 28
AT - Austria 26
AR - Argentina 25
TR - Turchia 23
JP - Giappone 22
MX - Messico 19
PH - Filippine 18
ZA - Sudafrica 18
IQ - Iraq 15
EC - Ecuador 14
UA - Ucraina 13
LT - Lituania 12
PK - Pakistan 12
MA - Marocco 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
VE - Venezuela 9
AU - Australia 8
KE - Kenya 8
PE - Perù 8
BE - Belgio 7
CL - Cile 7
TH - Thailandia 6
EG - Egitto 5
IR - Iran 5
MY - Malesia 5
RO - Romania 5
CO - Colombia 4
CR - Costa Rica 4
JM - Giamaica 4
JO - Giordania 4
NP - Nepal 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
GR - Grecia 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
OM - Oman 3
PY - Paraguay 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
MK - Macedonia 2
RS - Serbia 2
SV - El Salvador 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
GT - Guatemala 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
Totale 6.469
Salva come PNG Salva come JPEG
Città #
Singapore 344
Milan 306
Ashburn 300
San Jose 255
Hong Kong 207
Dallas 190
Ho Chi Minh City 145
Hanoi 139
Hefei 100
Ann Arbor 97
Los Angeles 91
New York 88
Frankfurt am Main 79
Dublin 76
Beijing 62
Seoul 51
Chicago 46
Santa Clara 43
The Dalles 38
Jakarta 37
Munich 35
Chandler 33
Toronto 32
Rome 31
Boardman 30
São Paulo 29
Buffalo 27
Council Bluffs 26
Desio 26
Lauterbourg 26
Moscow 25
Columbus 24
Zurich 24
Seveso 22
Fairfield 20
Helsinki 20
Kent 19
London 19
Montreal 18
Tokyo 18
Warsaw 18
Monza 17
Da Nang 16
Turku 16
Carate Brianza 15
Chennai 15
Haiphong 15
Houston 15
Stockholm 15
Atlanta 14
Nuremberg 14
Orem 14
Denver 13
Turin 13
Lissone 12
Phoenix 12
Poplar 12
Seattle 12
Shanghai 12
Vienna 12
Amsterdam 11
Brooklyn 11
Genoa 11
Johannesburg 11
Rio de Janeiro 11
Ha Long 10
Paris 10
Perugia 10
Tashkent 10
Boston 9
Ankara 8
Biên Hòa 8
Can Tho 8
Lima 8
Manchester 8
Quezon City 8
Brussels 7
Campinas 7
Cesano Maderno 7
Ithaca 7
Pune 7
Quận Bình Thạnh 7
Quận Một 7
San Diego 7
Seregno 7
Sesto San Giovanni 7
The Bronx 7
Wilmington 7
Baghdad 6
Brescia 6
Corsico 6
Curitiba 6
Florence 6
Forsyth 6
Lodz 6
Magenta 6
Nairobi 6
Princeton 6
Querétaro 6
Romola 6
Totale 3.788
Salva come PNG Salva come JPEG
Nome #
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 434
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 411
Investigation of drug resistance and co-mutational landscape of ALK-positive tumors 390
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 359
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 357
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 338
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 314
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 299
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 298
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 283
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 280
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering 278
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 277
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 274
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 260
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 242
New advances in liquid biopsy technologies for anaplastic lymphoma kinase (Alk)—positive cancer 236
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 234
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 223
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 201
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 191
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 163
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 146
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution 47
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models 38
Totale 6.573
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.877
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.877
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202264 0 6 4 4 10 5 8 3 7 6 3 8
2022/2023221 20 34 17 17 8 15 1 9 20 33 22 25
2023/2024477 41 22 22 20 59 94 73 16 34 23 30 43
2024/20251.551 52 94 88 78 105 58 98 43 181 255 156 343
2025/20263.897 485 322 402 496 365 182 517 148 255 350 135 240
2026/2027215 206 9 0 0 0 0 0 0 0 0 0 0
Totale 6.573